FMR LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 125 filers reported holding THERAPEUTICSMD INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q1 2022$308,000
-94.0%
808,461
-94.4%
0.00%
Q4 2021$5,150,000
-50.2%
14,487,880
+3.9%
0.00%
-100.0%
Q3 2021$10,340,000
-37.5%
13,947,536
+0.4%
0.00%0.0%
Q2 2021$16,538,000
-11.2%
13,897,859
-0.1%
0.00%
-50.0%
Q1 2021$18,634,000
+9.1%
13,906,105
-1.5%
0.00%0.0%
Q4 2020$17,081,000
-24.5%
14,116,461
-1.4%
0.00%0.0%
Q3 2020$22,610,000
+21.3%
14,310,153
-4.1%
0.00%0.0%
Q2 2020$18,646,000
+5.5%
14,915,899
-10.5%
0.00%0.0%
Q1 2020$17,666,000
-58.7%
16,666,018
-5.7%
0.00%
-60.0%
Q4 2019$42,780,000
-36.7%
17,677,475
-5.1%
0.01%
-37.5%
Q3 2019$67,594,000
+30.6%
18,620,930
-6.4%
0.01%
+33.3%
Q2 2019$51,740,000
-41.6%
19,900,041
+9.5%
0.01%
-45.5%
Q1 2019$88,527,000
+28.5%
18,178,211
+0.5%
0.01%
+22.2%
Q4 2018$68,917,000
-12.8%
18,088,341
+50.1%
0.01%0.0%
Q3 2018$79,048,000
+20.6%
12,049,988
+14.7%
0.01%
+12.5%
Q2 2018$65,563,000
-30.3%
10,507,001
-45.6%
0.01%
-27.3%
Q1 2018$94,093,000
-32.5%
19,320,740
-16.2%
0.01%
-31.2%
Q4 2017$139,335,000
-9.8%
23,068,840
-21.0%
0.02%
-15.8%
Q3 2017$154,478,000
+11.1%
29,201,840
+10.7%
0.02%
+11.8%
Q2 2017$139,030,000
-34.2%
26,381,470
-10.1%
0.02%
-37.0%
Q1 2017$211,250,000
+24.2%
29,340,231
-0.5%
0.03%
+17.4%
Q4 2016$170,141,000
-15.2%
29,487,031
+0.0%
0.02%
-14.8%
Q3 2016$200,717,000
-19.8%
29,473,829
+0.1%
0.03%
-20.6%
Q2 2016$250,236,000
+33.0%
29,439,555
+0.1%
0.03%
+30.8%
Q1 2016$188,208,000
-32.0%
29,407,553
+10.2%
0.03%
-29.7%
Q4 2015$276,632,000
+108.3%
26,676,206
+17.7%
0.04%
+94.7%
Q3 2015$132,822,000
-16.6%
22,665,886
+11.8%
0.02%
-5.0%
Q2 2015$159,340,000
+19.6%
20,272,286
-8.0%
0.02%
+17.6%
Q1 2015$133,254,000
+52.5%
22,025,406
+12.1%
0.02%
+54.5%
Q4 2014$87,398,000
-1.3%
19,640,071
+2.9%
0.01%
-8.3%
Q3 2014$88,542,000
+20.0%
19,082,239
+14.3%
0.01%
+20.0%
Q2 2014$73,787,000
-20.8%
16,694,039
+13.0%
0.01%
-23.1%
Q1 2014$93,205,000
+88.5%
14,770,904
+55.7%
0.01%
+85.7%
Q4 2013$49,437,000
+67.6%
9,488,780
-5.8%
0.01%
+40.0%
Q3 2013$29,503,000
-3.8%
10,069,321
-0.5%
0.01%0.0%
Q2 2013$30,669,00010,121,6210.01%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2022
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 4,115,116$4,979,0001.13%
GMT CAPITAL CORP 5,986,062$7,243,0000.52%
Rubric Capital Management LP 4,520,610$5,470,0000.40%
Handelsinvest Investeringsforvaltning 1,200,000$1,446,0000.22%
RA Capital Management 7,812,500$9,453,0000.13%
Knights of Columbus Asset Advisors LLC 705,105$853,0000.09%
GSA CAPITAL PARTNERS LLP 385,106$466,0000.08%
C WorldWide Group Holding A/S 6,189,834$7,490,0000.08%
Virtu Financial LLC 568,171$687,0000.07%
Aristides Capital LLC 156,747$190,0000.06%
View complete list of THERAPEUTICSMD INC shareholders